Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.92
Delayed Data
As of May 20
 -0.18 / -4.39%
Today’s Change
3.22
Today|||52-Week Range
13.91
+6.81%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Lea Leiv
Chief Financial Officer
Buy12/21/201824,700$4.15$102.5K-4.85%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/27/201820,000$3.29$65.8K+19.15%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/06/20185,000$5.99$30.0K-34.01%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/20/20185,000$4.40$22.0K-8.84%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/20/20185,000$4.39$22.0K-8.84%
Miller Richard A /vantage/
President & Chief Executive Officer
Buy12/04/20181,502$5.95$8.9K-34.45%
Miller Richard A /vantage/
President & Chief Executive Officer
Gift12/11/201810,000$0.00$0.00-30.37%
Miller Richard A /vantage/
President & Chief Executive Officer
Gift12/11/201810,000$0.00$0.00-30.37%